These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32201251)

  • 1. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
    Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
    Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
    Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
    Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
    Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
    J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of cystamine conjugated chitosan-SS-mPEG based 5-Fluorouracil loaded polymeric nanoparticles for redox responsive drug release.
    M GA; S AT; Ayyavu M; A S; Kandasamy R
    Eur J Pharm Sci; 2018 Apr; 116():37-47. PubMed ID: 29080854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the hypoxic tumor targeting ability of two chitosan micelles loaded with oil-soluble CdSe quantum dots.
    Zhang S; Zhao L; Qiu N; Liu Y; Xu B; Zhu H
    Pharm Dev Technol; 2018 Jan; 23(1):87-95. PubMed ID: 28782455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
    Wang F; Wang Y; Ma Q; Cao Y; Yu B
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
    Erdem M; Yalcin S; Gunduz U
    Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
    Bothiraja C; Rajput N; Poudel I; Rajalakshmi S; Panda B; Pawar A
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):447-461. PubMed ID: 29368543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
    Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
    Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
    Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
    Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSH-responsive and folate receptor-targeted pyridine bisfolate-encapsulated chitosan nanoparticles for enhanced intracellular drug delivery in MCF-7 cells.
    Elshami FI; Elrefaei G; Ibrahim MM; Elmehasseb I; Shaban SY
    Carbohydr Res; 2024 Sep; 543():109207. PubMed ID: 39018698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
    Zhang C; Zhang Z; Zhao L
    Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging.
    Xie P; Du P; Li J; Liu P
    Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
    Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
    AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.